FULCRUM THERAPEUTICS
3.6200
07-أكتوبر-24 12:12:11
15 متأخرة بدقائق
الأسهم
-0.2000
-5.24%
نطاق اليوم
3.6150 - 3.7800
ISIN
N/A
المصدر
NASDAQ
-
Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results
08 نوفمبر 2022 07:17:58 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Chief Medical Officer and Chief Scientific Officer
07 نوفمبر 2022 17:00:00 بحسب Nasdaq GlobeNewswire
-
02 نوفمبر 2022 07:05:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate at Upcoming November Investor Conferences
01 نوفمبر 2022 17:29:02 بحسب Nasdaq GlobeNewswire
-
12 أكتوبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 أكتوبر 2022 17:00:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 سبتمبر 2022 17:00:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at Upcoming September Investor Conferences
06 سبتمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate at the Upcoming Stifel 2022 Biotech Summer Summit
16 أغسطس 2022 07:05:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
15 أغسطس 2022 21:28:02 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
15 أغسطس 2022 16:08:15 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
11 أغسطس 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
04 أغسطس 2022 08:07:44 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 أغسطس 2022 08:00:02 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 يوليو 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Departure of Chief Medical Officer
11 يوليو 2022 17:00:00 بحسب Nasdaq GlobeNewswire
-
05 يوليو 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 يونيو 2022 16:02:00 بحسب Nasdaq GlobeNewswire
-
10 يونيو 2022 07:02:00 بحسب Nasdaq GlobeNewswire